Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets 8 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026
WillScot Mobile Mini Holdings Corp. – Consensus ‘strong_buy’ rating and 20.8% Upside Potential 20 December 2023
Encompass Health Corporation – Consensus ‘strong_buy’ rating and 21.6% Upside Potential 20 December 2023
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
ZIGUP reports higher underlying revenue and stronger rental performance in HY results 3 December 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Kingfisher PLC (KGF.L) Stock Analysis: Navigating a Challenging Landscape with a 3.84% Dividend Yield 12 January 2026
Vodafone Group (VOD.L) Investor Outlook: Navigating a Complex Landscape with a 3.88% Dividend Yield 12 January 2026
Weir Group PLC (WEIR.L) Stock Analysis: Exploring a 4.62% Potential Upside Amid Strong Buy Ratings 12 January 2026
Vistry Group PLC (VTY.L): Navigating Residential Construction with Insights on Analyst Ratings and Market Performance 12 January 2026
GSK PLC (GSK.L) Stock Analysis: Navigating Dividend Yield and Revenue Growth in the Healthcare Sector 12 January 2026